MediWound
MDWD
68 hedge funds and large institutions have $86M invested in MediWound in 2025 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 19 increasing their positions, 25 reducing their positions, and 5 closing their positions.
303% more call options, than puts
Call options by funds: $1.78M | Put options by funds: $441K
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
80% more first-time investments, than exits
New positions opened: 9 | Existing positions closed: 5
29% more capital invested
Capital invested by funds: $66.6M → $86M (+$19.4M)
6% more funds holding
Funds holding: 64 → 68 (+4)
2.97% more ownership
Funds ownership: 38.13% → 41.1% (+3%)
24% less repeat investments, than reductions
Existing positions increased: 19 | Existing positions reduced: 25
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$4.05M |
| 2 |
SBCM
Silverberg Bernstein Capital Management
Armonk,
New York
|
+$821K |
| 3 |
State Street
Boston,
Massachusetts
|
+$730K |
| 4 |
Millennium Management
New York
|
+$725K |
| 5 |
Citadel Advisors
Miami,
Florida
|
+$518K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RA
Rosalind Advisors
Toronto,
Ontario, Canada
|
-$1.88M |
| 2 |
BlackRock
New York
|
-$822K |
| 3 |
YLHM
Yelin Lapidot Holdings Management
Tel Aviv,
Israel
|
-$777K |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$566K |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
-$329K |
MDWD Hedge Fund Activity: Q2 2025 in Review
68 of the 7,596 institutional investors tracked by Wall St. Rank reported a position in MediWound (MDWD) for Q2 2025, worth a combined $86M — up 29% from $66.6M a quarter earlier.
Buyers outnumbered sellers: 9 funds opened new MDWD positions and 5 closed out — a net gain of 4 holders — while 19 added to existing stakes and 25 trimmed.
The largest buyer was T. Rowe Price Associates, adding an estimated $4.05M. The largest seller was Rosalind Advisors, cutting an estimated $1.88M.
- 68 institutional investors held MediWound (MDWD) as of Q2 2025, up from 64 in Q1 2025.
- Funds reported $86M of MediWound stock for Q2 2025, up 29% quarter-over-quarter.
- 9 funds opened new MediWound positions in Q2 2025 and 5 closed out, a net change of +4 holders.
- The largest MediWound buyer in Q2 2025 was T. Rowe Price Associates, an estimated $4.05M added.
- The largest MediWound seller in Q2 2025 was Rosalind Advisors, an estimated $1.88M sold.
Based on aggregated 13F filings for Q2 2025.